Status:
UNKNOWN
The Predictive Value of Alarm Symptoms in Patients With Dyspepsia Based on Roman IV
Lead Sponsor:
Second Affiliated Hospital of Xi'an Jiaotong University
Collaborating Sponsors:
Xijing Hospital
Tang-Du Hospital
Conditions:
Dyspepsia
Eligibility:
All Genders
18+ years
Brief Summary
Functional dyspepsia is one of the most common gastrointestinal disorders (FGIDs) encountered in clinical practice.Clinical diagnosis is notoriously unreliable in diagnosing the underlying cause of dy...
Detailed Description
Functional dyspepsia is one of the most common gastrointestinal disorders (FGIDs) encountered in clinical practice. Functional dyspepsia is a clinical syndrome characterized by chronic and recurrent g...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Aged 18 years and older;
- Presence of dyspeptic symptoms according with Rome IV criteria (Discomfort was characterized by the presence of one or more symptoms that included bothersome postprandial fullness, bothersome early satiation, bothersome epigastric pain, bothersome epigastric burning, Symptoms had to be present for at least 3 months within the preceding 6 months);
- From March 2018 to January 2019, patient went to the Gastroenterology clinics of the second affiliated hospital of xi'an jiaotong university, Xijing Hospital, Tangdu Hospital, Xi'an No.3 Hospital, and received gastroscopy;
- Upper abdominal ultrasonography, blood routine examination, liver function test were conducted within six months.
- Exclusion criteria:
- History of esophagitis or ulcer disease or other organic upper gastrointestinal disease, pancreaticobiliary disease, metabolic disease(abnormal thyroid function, diabetes );
- Were pregnant, might become pregnant, or were lactating;
- Major abdominal surgery;
- Severe neurological disorder, psychological diseases; or with severe hepatic, renal or respiratory dysfunction;
- Known or suspected liver dysfunction, including NASH, HBV or HCV-related hepatitis;
- History of gastroscope within 1 year;
- (6) Current antidepressant, steroids or NSAID use; (7) Patients who had only reflux-related symptoms or who had predominantly reflux-related symptoms; (8) Not willing to participate in the study.
Exclusion
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2019
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT03479528
Start Date
March 1 2018
End Date
January 31 2019
Last Update
January 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The second affiliated hospital of xi'an jiaotong university
Xi’an, Shanxi, China, 710004